We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Genedrive plc (GDR) Ordinary 1.5p Shares

Sell:5.50p Buy:6.00p 0 Change: 0.13p (2.13%)
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:6.00p
Change: 0.13p (2.13%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:5.50p
Buy:6.00p
Change: 0.13p (2.13%)
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

genedrive plc is a United Kingdom-based patient molecular diagnostics company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company offers products, including Genedrive MT-RNR1 ID Kit and Genedrive COV19-ID Kit. Genedrive MT-RNR1 ID Kit is a rapid genetic test in an emergency neonatal care setting. It has developed tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of hepatitis c virus (HCV), infection prior to drug administration, pathogen detection of biological military threats, and a point-of-care for COVID-19 detection system for us in areas such as healthcare, workplace screening, travel requirements, or confirmation of antigen tests.

Contact details

Address:
48 Grafton Street
MANCHESTER
M13 9XX
United Kingdom
Telephone:
+44 (0161) 9890245
Website:
www.genedriveplc.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 28 March 2024 28/03/24
AGM 29 December 2023 29/12/23
Annual report 06 December 2023 06/12/23
Final results 30 November 2023 30/11/23
AGM 30 November 2023 30/11/23
General meeting 11 May 2023 11/05/23

General stock information

EPIC:
GDR
ISIN:
GB00B1VKB244
Market cap:
£8.23 million
Shares in issue:
143.14 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • James Cheek
    Chief Executive Officer, Director
  • Russell Shaw
    Chief Financial Officer, Executive Director, Company Secretary
  • Gino Miele
    Chief Scientific Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.